Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability
Titel:
Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability
Auteur:
Klumpp, Klaus Smith, David Brandl, Michael Alfredson, Tom Sarma, Keshab Smith, Mark Najera, Isabel Jiang, Wen-Rong Le Pogam, Sophie Leveque, Vincent Ma, Han Tu, Yaping Chan, Rebecca Chen, Chiao-Wen Wu, Xiaoyang Birudaraj, Raj Swallow, Steven Martin, Joseph A. Cammack, Nick Berns, Heather Fettner, Scott Ipe, David Mannino, Marie O’Mara, Edward Washington, Carla Roberts, Stuart Cooksley, Graham Dore, Greg Shaw, David Blue Jr., David R. Zahm, Friederike Hill, George